Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs.

Markowska-Daniel I, Pomorska-Mól M, Pejsak Z.

Vet Immunol Immunopathol. 2011 Jul 15;142(1-2):81-6. doi: 10.1016/j.vetimm.2011.03.019.

PMID:
21501880
2.

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL.

Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):117-28.

PMID:
16621020
3.

Effect of maternal antibodies and pig age on the antibody response after vaccination against Glässers disease.

Pomorska-Mól M, Markowska-Daniel I, Rachubik J, Pejsak Z.

Vet Res Commun. 2011 Aug;35(6):337-43. doi: 10.1007/s11259-011-9478-6.

PMID:
21584780
5.

Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus.

Loeffen WL, Heinen PP, Bianchi AT, Hunneman WA, Verheijden JH.

Vet Immunol Immunopathol. 2003 Mar 20;92(1-2):23-35.

PMID:
12628761
6.

Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.

Platt R, Vincent AL, Gauger PC, Loving CL, Zanella EL, Lager KM, Kehrli ME Jr, Kimura K, Roth JA.

Vet Immunol Immunopathol. 2011 Aug 15;142(3-4):252-7. doi: 10.1016/j.vetimm.2011.05.005.

PMID:
21664701
7.

Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.

Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y.

Vaccine. 2010 Oct 8;28(43):7098-108. doi: 10.1016/j.vaccine.2010.08.003.

PMID:
20708697
8.

Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs.

Pyo HM, Hlasny M, Zhou Y.

Vaccine. 2015 Jul 17;33(31):3667-72. doi: 10.1016/j.vaccine.2015.06.044.

PMID:
26092308
10.
11.
12.

Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.

Kyriakis CS, Gramer MR, Barbé F, Van Doorsselaere J, Van Reeth K.

Vet Microbiol. 2010 Jul 29;144(1-2):67-74. doi: 10.1016/j.vetmic.2009.12.039.

PMID:
20116942
13.

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.

Van Reeth K, Gregory V, Hay A, Pensaert M.

Vaccine. 2003 Mar 28;21(13-14):1375-81.

PMID:
12615433
14.

Divergent immune responses and disease outcomes in piglets immunized with inactivated and attenuated H3N2 swine influenza vaccines in the presence of maternally-derived antibodies.

Sandbulte MR, Platt R, Roth JA, Henningson JN, Gibson KA, Rajão DS, Loving CL, Vincent AL.

Virology. 2014 Sep;464-465:45-54. doi: 10.1016/j.virol.2014.06.027.

15.
16.

Ceftiofur hydrochloride affects the humoral and cellular immune response in pigs after vaccination against swine influenza and pseudorabies.

Pomorska-Mól M, Czyżewska-Dors E, Kwit K, Wierzchosławski K, Pejsak Z.

BMC Vet Res. 2015 Oct 22;11:268. doi: 10.1186/s12917-015-0586-3.

17.
18.

Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.

Lee JH, Gramer MR, Joo HS.

Can J Vet Res. 2007 Jul;71(3):207-12.

19.

Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza.

van Maanen C, Bruin G, de Boer-Luijtze E, Smolders G, de Boer GF.

Vet Q. 1992 Jan;14(1):13-7.

PMID:
1574831
Items per page

Supplemental Content

Support Center